Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Estimating trends in the proportion of transmitted and acquired HIV drug resistance in a long term observational cohort in Germany.
Schmidt D, Kollan C, Fätkenheuer G, Schülter E, Stellbrink HJ, Noah C, Jensen BE, Stoll M, Bogner JR, Eberle J, Meixenberger K, Kücherer C, Hamouda O, Bartmeyer B; ClinSurv-HIV Drug Resistance Study Group in CHAIN. Schmidt D, et al. Among authors: bartmeyer b. PLoS One. 2014 Aug 22;9(8):e104474. doi: 10.1371/journal.pone.0104474. eCollection 2014. PLoS One. 2014. PMID: 25148412 Free PMC article.
Calculation of direct antiretroviral treatment costs and potential cost savings by using generics in the German HIV ClinSurv cohort.
Stoll M, Kollan C, Bergmann F, Bogner J, Faetkenheuer G, Fritzsche C, Hoeper K, Horst HA, van Lunzen J, Plettenberg A, Reuter S, Rockstroh J, Stellbrink HJ, Hamouda O, Bartmeyer B; ClinSurv Study Group. Stoll M, et al. Among authors: bartmeyer b. PLoS One. 2011;6(9):e23946. doi: 10.1371/journal.pone.0023946. Epub 2011 Sep 9. PLoS One. 2011. PMID: 21931626 Free PMC article.
First line treatment response in patients with transmitted HIV drug resistance and well defined time point of HIV infection: updated results from the German HIV-1 seroconverter study.
Zu Knyphausen F, Scheufele R, Kücherer C, Jansen K, Somogyi S, Dupke S, Jessen H, Schürmann D, Hamouda O, Meixenberger K, Bartmeyer B. Zu Knyphausen F, et al. Among authors: bartmeyer b. PLoS One. 2014 May 1;9(5):e95956. doi: 10.1371/journal.pone.0095956. eCollection 2014. PLoS One. 2014. PMID: 24788613 Free PMC article.
Everything counts - a method to determine viral suppression among people living with HIV using longitudinal data for the HIV care continuum - results of two large, German, multi-center real-life cohort studies over 20 years (1999-2018).
Schmidt D, Kollan C, Stoll M, Hamouda O, Bremer V, Kurth T, Bartmeyer B; HIV-1 Seroconverter cohort; ClinSurv HIV cohort. Schmidt D, et al. Among authors: bartmeyer b. BMC Public Health. 2021 Jan 22;21(1):200. doi: 10.1186/s12889-020-10088-7. BMC Public Health. 2021. PMID: 33482773 Free PMC article.
Improved testing of recent HIV-1 infections with the BioRad avidity assay compared to the limiting antigen avidity assay and BED Capture enzyme immunoassay: evaluation using reference sample panels from the German Seroconverter Cohort.
Hauser A, Santos-Hoevener C, Meixenberger K, Zimmermann R, Somogyi S, Fiedler S, Hofmann A, Bartmeyer B, Jansen K, Hamouda O, Bannert N, Kuecherer C. Hauser A, et al. Among authors: bartmeyer b. PLoS One. 2014 Jun 3;9(6):e98038. doi: 10.1371/journal.pone.0098038. eCollection 2014. PLoS One. 2014. PMID: 24892795 Free PMC article.
Assessment of ambiguous base calls in HIV-1 pol population sequences as a biomarker for identification of recent infections in HIV-1 incidence studies.
Meixenberger K, Hauser A, Jansen K, Yousef KP, Fiedler S, von Kleist M, Norley S, Somogyi S, Hamouda O, Bannert N, Bartmeyer B, Kücherer C. Meixenberger K, et al. Among authors: bartmeyer b. J Clin Microbiol. 2014 Aug;52(8):2977-83. doi: 10.1128/JCM.03289-13. Epub 2014 Jun 11. J Clin Microbiol. 2014. PMID: 24920768 Free PMC article.
67 results